Colinz Labs

Market Cap: Micro Cap
Industry: Pharmaceuticals & Drugs
ISIN: INE923C01011
NSEID:
BSEID: 531210

INR

48.08

-2.53 (-5.0%)

BSENSE

Apr 11, 12:37 PM

BSE+NSE Vol: 1.84 k

{
  "main_header": {
    "sid": 621096,
    "name": "Colinz Labs",
    "stock_name": "Colinz Labs",
    "full_name": "Colinz Laboratories Ltd",
    "name_url": "stocks-analysis/colinz-labs",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "48.08",
    "chg": -2.53,
    "chgp": "-5.0%",
    "dir": -1,
    "prev_price": "50.61",
    "mcapval": "22.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 531210,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Drugs",
    "ind_code": 4,
    "isin": "INE923C01011",
    "curr_date": "Apr 11, 12:37 PM",
    "curr_time": "23:42 PM",
    "bse_nse_vol": "1.84 k",
    "exc_status": "Active",
    "traded_date": "Apr 11, 2025",
    "traded_date_str": "2025 04 11",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://sandbox-www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/colinz-labs-621096-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Colinz Laboratories Faces Intense Selling Pressure Amid Significant Stock Price Decline",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/colinz-laboratories-faces-selling-pressure-declines-4-99-amid-six-day-losing-streak-1693666",
        "imagepath": "",
        "date": "2025-04-03 09:35:16",
        "description": "Colinz Laboratories Ltd is currently facing significant selling pressure, with the stock showing only sellers today. The company has experienced a notable decline, with a 4.99% drop in its stock price, contrasting sharply with the Sensex's decline of just 0.58%. This marks the sixth consecutive day of losses for Colinz Laboratories, resulting in a total decline of 26.47% over this period.\n\nIn terms of weekly performance, the stock has fallen by 18.53%, while the Sensex has only decreased by 1.85%. Despite a strong performance over the past month, where Colinz Laboratories saw a 35.25% increase compared to the Sensex's 4.22%, the recent trend indicates a reversal in fortunes. \n\nThe stock opened at Rs 62.12 today, hitting an intraday low of the same price, and has not shown any range in trading. While it remains above its 50-day, 100-day, and 200-day moving averages, it is currently below its 5-day and 20-day..."
      },
      {
        "title": "Colinz Laboratories Faces Intense Selling Pressure Amid Continued Price Declines",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/colinz-laboratories-faces-selling-pressure-with-5-decline-amidst-22-61-loss-over-five-days-2-1671859",
        "imagepath": "",
        "date": "2025-04-02 09:35:22",
        "description": "Colinz Laboratories Ltd is currently facing significant selling pressure, with the stock showing only sellers today. The stock has experienced a notable decline of 5.00% in its one-day performance, contrasting sharply with the Sensex, which gained 0.54%. This marks the fifth consecutive day of losses for Colinz Laboratories, resulting in a cumulative drop of 22.61% over this period.\n\nIn the past week, the stock has underperformed, with an 18.54% decline compared to the Sensex's modest decrease of 1.11%. While the stock had a strong performance over the past month, gaining 42.35%, its year-to-date performance has turned negative at -6.28%, against the Sensex's -2.18%.\n\nThe stock opened with a gap down today, starting at Rs 65.38, and reached an intraday low of the same price, indicating a lack of upward momentum. Despite being above the 20-day, 50-day, 100-day, and 200-day moving averages, it remains below t..."
      },
      {
        "title": "Colinz Laboratories Faces Intense Selling Pressure Amidst Notable Price Declines",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/colinz-laboratories-ltd-faces-9-74-decline-amid-significant-selling-pressure-and-losses-1657531",
        "imagepath": "",
        "date": "2025-04-01 10:15:22",
        "description": "Colinz Laboratories Ltd is currently facing significant selling pressure, with the stock showing only sellers today. The company has experienced consecutive days of losses, with a notable decline of 9.74% in just one day, contrasting sharply with the Sensex's modest drop of 0.70%. Over the past week, Colinz Laboratories has seen a total decline of 10.19%, while the Sensex has managed a slight gain of 0.20%.\n\nDespite a strong performance over the past month, where the stock rose by 49.84% compared to the Sensex's 5.28%, the recent trend indicates a shift in market sentiment. The stock's performance over three months shows a modest gain of 1.21%, while the Sensex has declined by 2.08%. However, the longer-term outlook remains positive, with a remarkable 83.28% increase over the past year, significantly outperforming the Sensex's 4.63%.\n\nPotential contributing factors to the current selling pressure may includ..."
      },
      {
        "title": "Colinz Laboratories Faces Intense Selling Pressure Amid Consecutive Losses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/colinz-laboratories-ltd-faces-significant-selling-pressure-declines-5-00-amid-ongoing-losses-1638654",
        "imagepath": "",
        "date": "2025-03-28 09:35:28",
        "description": "Colinz Laboratories Ltd is currently facing significant selling pressure, with the stock showing only sellers today. The company has experienced consecutive losses over the past three days, resulting in a total decline of 14.25%. Today, the stock opened with a gap down of 5%, reaching an intraday low of Rs 72.44. \n\nIn terms of performance, Colinz Laboratories has underperformed relative to the Sensex, which has only seen a minor decline of 0.20% today. Over the past week, the stock has dropped 5.47%, while the Sensex has gained 0.71%. Despite a strong performance over the past month, where the stock rose by 57.72%, the recent trend indicates a shift in market sentiment.\n\nThe stock's performance metrics reveal that it remains above its 20-day, 50-day, 100-day, and 200-day moving averages, but is currently below its 5-day moving average. This suggests a potential short-term weakness despite its longer-term ga..."
      },
      {
        "title": "Colinz Laboratories Faces Intense Selling Pressure Amid Recent Price Declines",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/colinz-laboratories-ltd-faces-selling-pressure-with-5-decline-amid-consecutive-losses-1621707",
        "imagepath": "",
        "date": "2025-03-27 09:40:24",
        "description": "Colinz Laboratories Ltd is currently facing significant selling pressure, with the stock showing only sellers today. The stock has experienced consecutive losses over the past two days, resulting in a total decline of 9.74%. Today, it opened with a notable gap down of 5%, reaching an intraday low of Rs 76.25. \n\nIn terms of performance, Colinz Laboratories has underperformed relative to the Sensex, which gained 0.19% today. Over the past week, the stock has shown a positive trend with a 4.47% increase, but this is overshadowed by its recent downturn. Despite a strong performance over the past month, where it rose by 58.85%, the current selling trend raises concerns.\n\nThe stock's performance metrics reveal that it has outperformed the Sensex over longer periods, including a remarkable 753.86% increase over the past five years. However, the current selling pressure may be attributed to various market dynamics,..."
      },
      {
        "title": "Colinz Laboratories Achieves 52-Week High Amid Market Fluctuations and Trend Reversal Signs",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/colinz-laboratories-hits-52-week-high-of-rs-88-7-amid-volatile-trading-session-1600140",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/ColinzLaborator_priceRelatedfactors_796362.png",
        "date": "2025-03-26 09:41:08",
        "description": "Colinz Laboratories has reached a new 52-week high of Rs. 88.7, following a 14-day streak of gains. Despite recent fluctuations and underperformance relative to its sector, the stock remains above key moving averages. Over the past year, it has seen substantial growth compared to the broader market."
      },
      {
        "title": "Colinz Laboratories Faces Selling Pressure Amid Notable Stock Price Decline",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/colinz-laboratories-faces-selling-pressure-with-5-00-decline-amidst-notable-losses-today-1600106",
        "imagepath": "",
        "date": "2025-03-26 09:35:27",
        "description": "Colinz Laboratories Ltd is currently facing significant selling pressure, with the stock showing only sellers today. The company has experienced a notable decline of 5.00% in its stock price, contrasting sharply with the Sensex, which has only dipped by 0.04%. This marks a trend reversal for Colinz Laboratories, which had enjoyed 14 consecutive days of gains prior to today’s downturn.\n\nIn terms of performance metrics, Colinz Laboratories has outperformed the Sensex over various time frames, including a remarkable 109.61% increase over the past year compared to the Sensex's 7.61%. However, the stock's recent performance today underperformed its sector by 4.18%. The stock opened with a 5% gain, reaching an intraday high of Rs. 88.7, but subsequently fell to a low of Rs. 81, indicating volatility.\n\nPotential contributing factors to the selling pressure may include profit-taking after a substantial rally, as th..."
      },
      {
        "title": "Colinz Laboratories Achieves All-Time High Stock Price Amidst Market Fluctuations",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/colinz-laboratories-achieves-all-time-high-stock-price-of-rs-88-7-today-1600042",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/ColinzLaborator_priceRelatedfactors_796331.png",
        "date": "2025-03-26 09:35:18",
        "description": "Colinz Laboratories has reached an all-time high stock price of Rs. 88.7 after a 14-day gain streak, despite a recent decline. The stock has shown strong performance metrics, with significant increases over the past month and year, while currently trading above key moving averages."
      },
      {
        "title": "Colinz Laboratories Achieves 52-Week High Amid Strong Market Performance Trends",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/colinz-laboratories-achieves-52-week-high-of-rs-84-48-amid-strong-market-performance-1577612",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/ColinzLaborator_priceRelatedfactors_774850.png",
        "date": "2025-03-25 09:39:59",
        "description": "Colinz Laboratories has reached a new 52-week high of Rs. 84.48, reflecting a significant performance increase. The stock has gained 93.58% over the past 14 days and is trading above multiple moving averages. In the last year, it has delivered a 117.68% return, outperforming the broader market."
      }
    ],
    "total": 65,
    "sid": "621096",
    "stock_news_url": "https://sandbox-www.marketsmojo.com/news/colinz-laboratories-621096"
  },
  "announcements": [
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "07-Apr-2025",
      "details": "Please find the attached certificate under Regulation 74(5) of SEBI(Regulationss0 2018 for the Quarter ended Mar-2025 received form our RTA M/s. BIgshare Services Pvt. Ltd. Kindly take the same on records.",
      "source": "BSE"
    },
    {
      "caption": "Confirmation Of Not Being Identified As Large Corporate In Terms Of SEBI Circular No. SEBI/HO/DDHS/CIR/P/2018/144 Dated November 26 2018 - Fund Raising By Issuance Of Debt Securities By Large Entities",
      "datetime": "03-Apr-2025",
      "details": "with reference to the captioned subject we Colinz Laboratories Ltd (the Company) do hereby confirm that we do not fulfill the criteria mentioned at para 2.2 of the said circular w. r. t. applicability framework for Large Corporate (LC). therefore the filing of Annual Disclosure under said circular for the Year ended 31-03-2024 does not arise.",
      "source": "BSE"
    },
    {
      "caption": "Non - Applicability Of Annual Secretarial Compliance Report Under Regulation 24A Of SEBI (LODR) Regulations 2015 (As Amended) Read With SEBI Circular No. CIR/CFD/CMD1/27/2019 Dated 8Th February 2019 BSE Circular Nos. LIST/COMP/10/2019-20 Dated 9Th May 201",
      "datetime": "03-Apr-2025",
      "details": "This is to inform you that Annual Secretarial Compliance under Regulation 24A of SEBI(LODR) Regulation 2018 read with SEBI circular dated 8/2/2019 and BSE Circular dated 9-5-2019 and 14/5/2019is not applicable to our Company as Company is claiming exemption under Regulation 15(2) (a) of SEBI(LODR) Regulation 2015.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Colinz Laboratories Faces Intense Selling Pressure Amid Significant Stock Price Decline

2025-04-03 09:35:16

Colinz Laboratories Ltd is currently facing significant selling pressure, with the stock showing only sellers today. The company has experienced a notable decline, with a 4.99% drop in its stock price, contrasting sharply with the Sensex's decline of just 0.58%. This marks the sixth consecutive day of losses for Colinz Laboratories, resulting in a total decline of 26.47% over this period. In terms of weekly performance, the stock has fallen by 18.53%, while the Sensex has only decreased by 1.85%. Despite a strong performance over the past month, where Colinz Laboratories saw a 35.25% increase compared to the Sensex's 4.22%, the recent trend indicates a reversal in fortunes. The stock opened at Rs 62.12 today, hitting an intraday low of the same price, and has not shown any range in trading. While it remains above its 50-day, 100-day, and 200-day moving averages, it is currently below its 5-day and 20-day...

Colinz Laboratories Faces Intense Selling Pressure Amid Continued Price Declines

2025-04-02 09:35:22

Colinz Laboratories Ltd is currently facing significant selling pressure, with the stock showing only sellers today. The stock has experienced a notable decline of 5.00% in its one-day performance, contrasting sharply with the Sensex, which gained 0.54%. This marks the fifth consecutive day of losses for Colinz Laboratories, resulting in a cumulative drop of 22.61% over this period. In the past week, the stock has underperformed, with an 18.54% decline compared to the Sensex's modest decrease of 1.11%. While the stock had a strong performance over the past month, gaining 42.35%, its year-to-date performance has turned negative at -6.28%, against the Sensex's -2.18%. The stock opened with a gap down today, starting at Rs 65.38, and reached an intraday low of the same price, indicating a lack of upward momentum. Despite being above the 20-day, 50-day, 100-day, and 200-day moving averages, it remains below t...

Colinz Laboratories Faces Intense Selling Pressure Amidst Notable Price Declines

2025-04-01 10:15:22

Colinz Laboratories Ltd is currently facing significant selling pressure, with the stock showing only sellers today. The company has experienced consecutive days of losses, with a notable decline of 9.74% in just one day, contrasting sharply with the Sensex's modest drop of 0.70%. Over the past week, Colinz Laboratories has seen a total decline of 10.19%, while the Sensex has managed a slight gain of 0.20%. Despite a strong performance over the past month, where the stock rose by 49.84% compared to the Sensex's 5.28%, the recent trend indicates a shift in market sentiment. The stock's performance over three months shows a modest gain of 1.21%, while the Sensex has declined by 2.08%. However, the longer-term outlook remains positive, with a remarkable 83.28% increase over the past year, significantly outperforming the Sensex's 4.63%. Potential contributing factors to the current selling pressure may includ...

Colinz Laboratories Faces Intense Selling Pressure Amid Consecutive Losses

2025-03-28 09:35:28

Colinz Laboratories Ltd is currently facing significant selling pressure, with the stock showing only sellers today. The company has experienced consecutive losses over the past three days, resulting in a total decline of 14.25%. Today, the stock opened with a gap down of 5%, reaching an intraday low of Rs 72.44. In terms of performance, Colinz Laboratories has underperformed relative to the Sensex, which has only seen a minor decline of 0.20% today. Over the past week, the stock has dropped 5.47%, while the Sensex has gained 0.71%. Despite a strong performance over the past month, where the stock rose by 57.72%, the recent trend indicates a shift in market sentiment. The stock's performance metrics reveal that it remains above its 20-day, 50-day, 100-day, and 200-day moving averages, but is currently below its 5-day moving average. This suggests a potential short-term weakness despite its longer-term ga...

Colinz Laboratories Faces Intense Selling Pressure Amid Recent Price Declines

2025-03-27 09:40:24

Colinz Laboratories Ltd is currently facing significant selling pressure, with the stock showing only sellers today. The stock has experienced consecutive losses over the past two days, resulting in a total decline of 9.74%. Today, it opened with a notable gap down of 5%, reaching an intraday low of Rs 76.25. In terms of performance, Colinz Laboratories has underperformed relative to the Sensex, which gained 0.19% today. Over the past week, the stock has shown a positive trend with a 4.47% increase, but this is overshadowed by its recent downturn. Despite a strong performance over the past month, where it rose by 58.85%, the current selling trend raises concerns. The stock's performance metrics reveal that it has outperformed the Sensex over longer periods, including a remarkable 753.86% increase over the past five years. However, the current selling pressure may be attributed to various market dynamics,...

Colinz Laboratories Achieves 52-Week High Amid Market Fluctuations and Trend Reversal Signs

2025-03-26 09:41:08

Colinz Laboratories has reached a new 52-week high of Rs. 88.7, following a 14-day streak of gains. Despite recent fluctuations and underperformance relative to its sector, the stock remains above key moving averages. Over the past year, it has seen substantial growth compared to the broader market.

Colinz Laboratories Faces Selling Pressure Amid Notable Stock Price Decline

2025-03-26 09:35:27

Colinz Laboratories Ltd is currently facing significant selling pressure, with the stock showing only sellers today. The company has experienced a notable decline of 5.00% in its stock price, contrasting sharply with the Sensex, which has only dipped by 0.04%. This marks a trend reversal for Colinz Laboratories, which had enjoyed 14 consecutive days of gains prior to today’s downturn. In terms of performance metrics, Colinz Laboratories has outperformed the Sensex over various time frames, including a remarkable 109.61% increase over the past year compared to the Sensex's 7.61%. However, the stock's recent performance today underperformed its sector by 4.18%. The stock opened with a 5% gain, reaching an intraday high of Rs. 88.7, but subsequently fell to a low of Rs. 81, indicating volatility. Potential contributing factors to the selling pressure may include profit-taking after a substantial rally, as th...

Colinz Laboratories Achieves All-Time High Stock Price Amidst Market Fluctuations

2025-03-26 09:35:18

Colinz Laboratories has reached an all-time high stock price of Rs. 88.7 after a 14-day gain streak, despite a recent decline. The stock has shown strong performance metrics, with significant increases over the past month and year, while currently trading above key moving averages.

Colinz Laboratories Achieves 52-Week High Amid Strong Market Performance Trends

2025-03-25 09:39:59

Colinz Laboratories has reached a new 52-week high of Rs. 84.48, reflecting a significant performance increase. The stock has gained 93.58% over the past 14 days and is trading above multiple moving averages. In the last year, it has delivered a 117.68% return, outperforming the broader market.

View All News

Announcement

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

07-Apr-2025 | Source : BSE

Please find the attached certificate under Regulation 74(5) of SEBI(Regulationss0 2018 for the Quarter ended Mar-2025 received form our RTA M/s. BIgshare Services Pvt. Ltd. Kindly take the same on records.

Confirmation Of Not Being Identified As Large Corporate In Terms Of SEBI Circular No. SEBI/HO/DDHS/CIR/P/2018/144 Dated November 26 2018 - Fund Raising By Issuance Of Debt Securities By Large Entities

03-Apr-2025 | Source : BSE

with reference to the captioned subject we Colinz Laboratories Ltd (the Company) do hereby confirm that we do not fulfill the criteria mentioned at para 2.2 of the said circular w. r. t. applicability framework for Large Corporate (LC). therefore the filing of Annual Disclosure under said circular for the Year ended 31-03-2024 does not arise.

Non - Applicability Of Annual Secretarial Compliance Report Under Regulation 24A Of SEBI (LODR) Regulations 2015 (As Amended) Read With SEBI Circular No. CIR/CFD/CMD1/27/2019 Dated 8Th February 2019 BSE Circular Nos. LIST/COMP/10/2019-20 Dated 9Th May 201

03-Apr-2025 | Source : BSE

This is to inform you that Annual Secretarial Compliance under Regulation 24A of SEBI(LODR) Regulation 2018 read with SEBI circular dated 8/2/2019 and BSE Circular dated 9-5-2019 and 14/5/2019is not applicable to our Company as Company is claiming exemption under Regulation 15(2) (a) of SEBI(LODR) Regulation 2015.